Connecting with orthopedic experts and expanding our knowledge of musculoskeletal therapies: Why T3 is eager to attend AAOS 2017!

Share

Connect with T3 Labs at AAOS 2017- Booth #1956

The American Academy of Orthopaedic Surgeons’ Annual Meeting (AAOS) is the premier ortho event of the year: hosting thousands of thought leaders, physicians, scientists and academics seeking the latest in injury prevention and disease treatment of the musculoskeletal system. AAOS 2017 will bring the top names in orthopedics together in San Diego from March 14th to the 18th, so of course, the T3 team is excited to attend.

Not only will we be attending AAOS 2017, GCMI and T3 Labs will have a booth this year (#1956)! Having a dedicated space means that we will be able to connect with more people, be they physicians, researchers, small or large medical device companies, or other affiliated professionals with a novel idea for an orthopedic innovation. We are going to take advantage of the opportunity to meet and connect with industry leaders face-to-face, all the while learning how we can better translate their orthopedic innovations through the various stages of development: concept to commercialization.

We also look forward to the opportunity to catch up with the orthopedic sponsors that we have worked with in the past! As an industry leading preclinical CRO, T3 Labs prides itself on meeting the top needs for ortho professionals seeking preclinical testing, translation and bioskills training services.

Providing access to the multidisciplinary professionals critical to the success of novel medical technologies
Our recent joining of forces with GCMI gives us the capability to run the full process i.e understanding the clinical need, market analysis design, prototyping, preclinical testing, translation, commercialization, and training- all with one team.

“With a solid, team-based plan in place, the moment we had our implants ready, T3 Labs was ready to do the cadaveric study. They had the instrumentation we needed and the pilot work progressed very quickly. Many times you find yourself waiting on preclinical due to scheduling difficulties. This was not the case with T3 once we were ready to go, there was no delay. Any challenges were addressed quickly and correctly.” – Janet Krevolin, Ph.D., Chief Technical Officer of Bio2 Technologies

Read more about how we helped Bio2 Tech meet their preclinical needs for the first structural, completely porous bioactive glass receiving FDA 510k approval in 14 months.

Expanding our knowledge and orthopedic prowess
From sessions on healthcare marketing and ortho applications to use in your practice to the topical educational portions with experts- AAOS is an all-inclusive conference. You can view the AAOS 2017 preliminary program here.

If you are a physician innovator with an idea for a new orthopedic device, a medical device company gauging your product’s readiness for preclinical, or if you just want to talk about the latest in orthopedic therapies, stop by booth 1956 to connect with us! We will have experts from the GCMI and T3 team in tow- Mike Fisher, Director of product development for translational medicine and medical devices at GCMI who has 20 years of experience developing and commercializing medical products and Ashley Strong, DVM who has combined 20 years of clinical and pre-clinical, lab animal and veterinary experience.

You can call (404)894-5227 or email Deepal Panchal, Andrew Stevenson, or Evan Goldberg to schedule an onsite meeting at AAOS 2017!